Research to Treat Neurodegenerative Diseases Advances: URMC Start-up Acquired
Oscine Therapeutics – a biotechnology company that is developing cell-based therapies for neurological disorders based…
Oscine Therapeutics – a biotechnology company that is developing cell-based therapies for neurological disorders based…
The Fall 2020 round of the University’s Technology Development Fund (TDF) is now open. The…
Want to further your understanding around IP, entrepreneurship and commercialization? URventures has compiled a list…
ROCHESTER, N.Y., June 12, 2020 – Employers across the country can advance reopening efforts with technology…
May 27, 2020 Lindsey Valich / lvalich@ur.rochester.edu A person who has a stroke that causes…
Once again, the University of Rochester ranked among the top 100 worldwide universities granted U.S….
Given the changing circumstances due to the Covid-19 pandemic, URVentures has decided to cancel the…
CNY Biotech Accelerator, a division of the State University of New York Upstate Medical University,…